This immersive scenario thrusts participants into an unfolding, true-to-life story about a fictional, unstable country and a multinational bank’s risk exposure in this country when sanctions are imposed.
Our TPRM Summit brings compliance and procurement professionals together for two days solely dedicated to the sharing of knowledge and experience within third-party risk management.
Compliance Week is registered with the National Association of State Boards of Accountancy (NASBA) as a sponsor of continuing professional education on the National Registry of CPE Sponsors.
The high price on Biogen’s $900 million settlement for False Claims Act (FCA) violations shows the government is still keenly interested in cases of illegal kickbacks in physician referrals, experts and attorneys said.
“It’s a wake-up call to companies that they need to remain diligent in their compliance in this area,” said David Colapinto, partner at whistleblower law firm Kohn, Kohn & Colapinto.
Last month, Biogen finalized settlement of the lawsuit, after years of litigation by former employee Michael Bawduniak. Bawduniak, represented by boutique law firm Greene, alleged the company paid illegal kickbacks to doctors to induce them to prescribe Biogen’s multiple sclerosis drugs.
THIS IS MEMBERS-ONLY CONTENT. To continue reading, choose one of the options below.
News and analysis for the well-informed compliance or audit exec.
Trial Membership
First month free, then $499 for an annual Membership
Cancel anytime within the trial period.
Annual Membership best value
Subscribe now for $365
Our lowest price ($1 per day) for one year.
